Are Cancer Drugs Worth the Price?

Margaret Kyle holds the Chair in Intellectual Property and Markets for Technology at Mines-Paris PSL. She has previously held academic positions at the Toulouse School of Economics, London Business School, Duke University, Carnegie Mellon University, and was a visiting professor at Kellogg School of Management and the University of Hong Kong. Her research focuses on innovation, productivity, and competition, particularly in the pharmaceutical industry.
In this talk, Professor Kyle will discuss her work, co-authored with Pierre Dubois, on the effect of pharmaceutical innovation on cancer mortality rates. Cancer is a leading cause of death in developed countries, and cancer treatments are the top category of pharmaceutical spending in the United States and Europe. This paper investigates whether novel cancer therapies reduce mortality and their cost per statistical life year saved. The study analyzes data from 24 countries and 22 cancer sites over 20 years, examining the causal relationship between the availability of approved treatments and cancer-specific mortality.
Social event will follow at: 18:00 (post-seminar)
CLICK HERE FOR REGISTRATION
Complimentary aperitivo at Cantina Carducci, Via Giosuè Carducci, 9. A Young Scholar Initiative (YSI) event.
Note: For organizational efficiency, registration is important. The complimentary aperitivo has limited space, available on a first-come, first-served basis, with registered seminar attendees receiving priority. However, participation in the seminar remains possible also without registration and the aperitivo will be, in the worst case, at the at the expense of the participants.